CHIMERIC THERAPEUTICS LIMITED - Announcements

Market Cap $24.70M Add to my watchlist

Healthcare Biotechnology

Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company.... Chimeric Therapeutics Limited is an Australia-based clinical-stage cell therapy company. The Company is focused on the discovery, development, and commercialization of cell therapies for patients with cancer. Its pipeline includes CHM 1101 and CHM 2101. Its CHM 1101 (CLTX CAR-T) is a CAR-T therapy developed for the treatment of patients with solid tumors. CHM-1101 is being studied in a Phase I clinical trial in recurrent/ progressive glioblastoma. CHM 2101 is a third generation CDH17 CAR T, which is in preclinical development with a planned Phase I clinical trial in neuroendocrine tumors, colorectal, pancreatic and gastric cancer. Its pipeline also includes the CORE-NK platform, a clinically validated, off-the-shelf natural killer (NK) cell therapy platform to their portfolio (CHM 0201). The Company is also focused on the development of four NK and CAR NK assets with plans for Phase I clinical trials in solid tumors and blood cancers.More

BlinkLab Limited (ASX: BB1) is a trailblazer in digital healthcare, leveraging AI and machine learning in mobile applications to revolutioniSe neurodevelopmental condition diagnosis like ASD and ADHD. Born from extensive research at Princeton University,...

Announcements

Filter Results

All Price Sensitive Only

CHM	Notice under section 708A		02/05/24	202.5KB	Share
CHM	Application for quotation of securities - CHM		02/05/24	15.76KB	Share
CHM	Dr Rebecca McQualter appointed COO		02/05/24	224.64KB	Share
CHM	Resignation of CEO and Managing Director	PRICE SENSITIVE	01/05/24	170.33KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	30/04/24	1.55MB	Share
CHM	Change of Director's Interest Notice PH		08/04/24	170.14KB	Share
CHM	Change of Director's Interest Notice PH		08/04/24	211.99KB	Share
CHM	US patent allowed for CHM 0201 (CORE-NK) technology		05/04/24	172.62KB	Share
CHM	Notification of cessation of securities - CHM		02/04/24	12.78KB	Share
CHM	Notice under section 708A		28/03/24	202.53KB	Share
CHM	Application for quotation of securities - CHM		28/03/24	15.8KB	Share
CHM	Chimeric to present at NWR Virtual Healthcare Conference		15/03/24	171.83KB	Share
CHM	Clinical milestones for 2024 & 2023 successes highlighted	PRICE SENSITIVE	14/03/24	267.67KB	Share
CHM	Notification of cessation of securities - CHM		07/03/24	13.49KB	Share
CHM	Notice under section 708A		29/02/24	203.08KB	Share
CHM	Half Yearly Report and Accounts	PRICE SENSITIVE	29/02/24	1.87MB	Share
CHM	Application for quotation of securities - CHM		28/02/24	15.79KB	Share
CHM	Chimeric to present at ShareCafe Hidden Gems webinar		28/02/24	171.46KB	Share
CHM	Late lodgement of Appendix 3Y		15/02/24	333.3KB	Share
CHM	1st patient treated in ADVENT-AML Phase 1b clinical trial	PRICE SENSITIVE	08/02/24	196.21KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/01/24	297.36KB	Share
CHM	Application for quotation of securities - CHM		24/01/24	24.77KB	Share
CHM	Investor Presentation		18/01/24	8.75MB	Share
CHM	Placement of Entitlement Offer Shortfall	PRICE SENSITIVE	18/01/24	200.57KB	Share
CHM	ADVENT-AML Phase 1B clinical trial open to enrolment	PRICE SENSITIVE	15/01/24	197KB	Share
CHM	CHIMERIC RECEIVES $7.36M R&D TAX INCENTIVE	PRICE SENSITIVE	10/01/24	172.69KB	Share
CHM	Notice Under Section 708A		05/01/24	202.47KB	Share
CHM	Notification regarding unquoted securities - CHM		05/01/24	26.24KB	Share
CHM	Application for quotation of securities - CHM		05/01/24	25.43KB	Share
CHM	Proposed issue of securities - CHM		04/01/24	24.39KB	Share
CHM	Proposed issue of securities - CHM		04/01/24	24.44KB	Share
CHM	CHM Secures Further $1M Investment		04/01/24	196.74KB	Share
CHM	Notice under section 708A		22/12/23	202.39KB	Share
CHM	Application for quotation of securities - CHM		22/12/23	25.02KB	Share
CHM	Notification regarding unquoted securities - CHM		22/12/23	23.71KB	Share
CHM	Chimeric to present at Biotech Showcase at JPM week		21/12/23	172.96KB	Share
CHM	ADVENT-AML clinical trial GMP manufacturing complete		19/12/23	197.85KB	Share
CHM	Notice under section 708A		15/12/23	202.34KB	Share
CHM	Change of Director's Interest Notice JC		15/12/23	238.57KB	Share
CHM	Notification of cessation of securities - CHM		15/12/23	22.2KB	Share
CHM	Notification regarding unquoted securities - CHM		15/12/23	26.63KB	Share
CHM	Notification regarding unquoted securities - CHM		15/12/23	27.35KB	Share
CHM	Application for quotation of securities - CHM		15/12/23	33.85KB	Share
CHM	Change of Director's Interest Notice PHa		14/12/23	185.13KB	Share
CHM	Application for quotation of securities - CHM		07/12/23	24.93KB	Share
CHM	Completion of Entitlement Offer	PRICE SENSITIVE	07/12/23	167.31KB	Share
CHM	Positive in vitro data for CHM 1301 CAR NK cells-supplement		28/11/23	223.63KB	Share
CHM	Program update webinar with executive team - Tuesday 28 Nov		24/11/23	208.4KB	Share
CHM	Positive in vitro data for CHM 1301 CAR NK cells	PRICE SENSITIVE	23/11/23	217.9KB	Share
CHM	Amended Constitution		22/11/23	573.94KB	Share
CHM	Phase 1B ADVENT-AML trial to be presented at ASH meeting		20/11/23	219.57KB	Share
CHM	Update - Proposed issue of securities - CHM		15/11/23	28.27KB	Share
CHM	Entitlement Offer closing date extended to 30 November 2023		15/11/23	193.75KB	Share
CHM	Results of Annual General Meeting		14/11/23	228.67KB	Share
CHM	Presentation to Annual General Meeting		14/11/23	1.72MB	Share
CHM	Notice under section 708A		03/11/23	202KB	Share
CHM	Application for quotation of securities - CHM		03/11/23	25.02KB	Share
CHM	1st patient dosed in Phase 1b recurrent glioblastoma trial	PRICE SENSITIVE	02/11/23	197.43KB	Share
CHM	Entitlement Offer Documents		02/11/23	4.22MB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/10/23	887.35KB	Share
CHM	FDA clearance of IND for CHM 2101	PRICE SENSITIVE	31/10/23	197.28KB	Share
CHM	Entitlement Offer update to timetable		25/10/23	208.91KB	Share
CHM	Entitlement Offer cleansing notice under section 708AA		25/10/23	233.51KB	Share
CHM	Proposed issue of securities - CHM		25/10/23	24.47KB	Share
CHM	Investor Presentation - Entitlement Offer		25/10/23	2.96MB	Share
CHM	Proposed issue of securities - CHM		25/10/23	28.61KB	Share
CHM	Entitlement Offer to raise approximately $10 million	PRICE SENSITIVE	25/10/23	254.68KB	Share
CHM	New data for Phase 1A CLTX CAR T brain cancer clinical trial	PRICE SENSITIVE	23/10/23	424.1KB	Share
CHM	Trading Halt	PRICE SENSITIVE	20/10/23	568.27KB	Share
CHM	Notice of Annual General Meeting/Proxy Form		16/10/23	660.58KB	Share
CHM	Notice under section 708A		04/10/23	222.5KB	Share
CHM	Application for quotation of securities - CHM		04/10/23	24.99KB	Share
CHM	ESG Report		28/09/23	369.58KB	Share
CHM	Appendix 4G		28/09/23	267.62KB	Share
CHM	Corporate Governance Statement		28/09/23	164.18KB	Share
CHM	Annual Report to shareholders		28/09/23	2.09MB	Share
CHM	Notification regarding unquoted securities - CHM		19/09/23	23.66KB	Share
CHM	Results of Extraordinary General Meeting		13/09/23	213.71KB	Share
CHM	EGM Presentation		13/09/23	1.57MB	Share
CHM	Agreement with MD Anderson for Phase 1B CHM 0201 AML study	PRICE SENSITIVE	13/09/23	277.45KB	Share
CHM	Appendix 4E and Preliminary Final Report	PRICE SENSITIVE	31/08/23	1.06MB	Share
CHM	Final Director's Interest Notice CE		31/08/23	231.55KB	Share
CHM	Initial Director's Interest Notice ES		31/08/23	201.19KB	Share
CHM	Non-Executive Director Board Changes		30/08/23	172.91KB	Share
CHM	Dosing completion in Phase 1A brain cancer clinical trial	PRICE SENSITIVE	29/08/23	197.16KB	Share
CHM	Late lodgement of Appendix 3Y		28/08/23	360.22KB	Share
CHM	Chimeric to receive A$4.4 million introduction fee	PRICE SENSITIVE	16/08/23	170.91KB	Share
CHM	Positive data - CHM 0301 next-gen armoured NK cell platform	PRICE SENSITIVE	15/08/23	270.01KB	Share
CHM	Notice of Extraordinary General Meeting/Proxy Form		15/08/23	832.88KB	Share
CHM	Final Director's Interest Notice		03/08/23	218.87KB	Share
CHM	Resignation of Director		03/08/23	169.92KB	Share
CHM	Quarterly Activities/Appendix 4C Cash Flow Report	PRICE SENSITIVE	31/07/23	1.24MB	Share
CHM	Patent allowance for Chlorotoxin in Japan		27/07/23	170.84KB	Share
CHM	Change in substantial holding PH		17/07/23	269.99KB	Share
CHM	Final Director's Interest Notice LC		17/07/23	214.02KB	Share
CHM	Initial Director's Interest Notice PH		17/07/23	175.02KB	Share
CHM	Change of Director's Interest Notice x 6		17/07/23	333.96KB	Share
CHM	Notice under section 708A		14/07/23	221.12KB	Share
CHM	Notification regarding unquoted securities - CHM		14/07/23	25.97KB	Share
CHM	Application for quotation of securities - CHM		14/07/23	24.69KB	Share

CHM Notice under section 708A
02/05/24		202.5KB	Share
CHM Application for quotation of securities - CHM
02/05/24		15.76KB	Share
CHM Dr Rebecca McQualter appointed COO
02/05/24		224.64KB	Share
CHM Resignation of CEO and Managing Director
01/05/24	PRICE SENSITIVE	170.33KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
30/04/24	PRICE SENSITIVE	1.55MB	Share
CHM Change of Director's Interest Notice PH
08/04/24		170.14KB	Share
CHM Change of Director's Interest Notice PH
08/04/24		211.99KB	Share
CHM US patent allowed for CHM 0201 (CORE-NK) technology
05/04/24		172.62KB	Share
CHM Notification of cessation of securities - CHM
02/04/24		12.78KB	Share
CHM Notice under section 708A
28/03/24		202.53KB	Share
CHM Application for quotation of securities - CHM
28/03/24		15.8KB	Share
CHM Chimeric to present at NWR Virtual Healthcare Conference
15/03/24		171.83KB	Share
CHM Clinical milestones for 2024 & 2023 successes highlighted
14/03/24	PRICE SENSITIVE	267.67KB	Share
CHM Notification of cessation of securities - CHM
07/03/24		13.49KB	Share
CHM Notice under section 708A
29/02/24		203.08KB	Share
CHM Half Yearly Report and Accounts
29/02/24	PRICE SENSITIVE	1.87MB	Share
CHM Application for quotation of securities - CHM
28/02/24		15.79KB	Share
CHM Chimeric to present at ShareCafe Hidden Gems webinar
28/02/24		171.46KB	Share
CHM Late lodgement of Appendix 3Y
15/02/24		333.3KB	Share
CHM 1st patient treated in ADVENT-AML Phase 1b clinical trial
08/02/24	PRICE SENSITIVE	196.21KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/01/24	PRICE SENSITIVE	297.36KB	Share
CHM Application for quotation of securities - CHM
24/01/24		24.77KB	Share
CHM Investor Presentation
18/01/24		8.75MB	Share
CHM Placement of Entitlement Offer Shortfall
18/01/24	PRICE SENSITIVE	200.57KB	Share
CHM ADVENT-AML Phase 1B clinical trial open to enrolment
15/01/24	PRICE SENSITIVE	197KB	Share
CHM CHIMERIC RECEIVES $7.36M R&D TAX INCENTIVE
10/01/24	PRICE SENSITIVE	172.69KB	Share
CHM Notice Under Section 708A
05/01/24		202.47KB	Share
CHM Notification regarding unquoted securities - CHM
05/01/24		26.24KB	Share
CHM Application for quotation of securities - CHM
05/01/24		25.43KB	Share
CHM Proposed issue of securities - CHM
04/01/24		24.39KB	Share
CHM Proposed issue of securities - CHM
04/01/24		24.44KB	Share
CHM CHM Secures Further $1M Investment
04/01/24		196.74KB	Share
CHM Notice under section 708A
22/12/23		202.39KB	Share
CHM Application for quotation of securities - CHM
22/12/23		25.02KB	Share
CHM Notification regarding unquoted securities - CHM
22/12/23		23.71KB	Share
CHM Chimeric to present at Biotech Showcase at JPM week
21/12/23		172.96KB	Share
CHM ADVENT-AML clinical trial GMP manufacturing complete
19/12/23		197.85KB	Share
CHM Notice under section 708A
15/12/23		202.34KB	Share
CHM Change of Director's Interest Notice JC
15/12/23		238.57KB	Share
CHM Notification of cessation of securities - CHM
15/12/23		22.2KB	Share
CHM Notification regarding unquoted securities - CHM
15/12/23		26.63KB	Share
CHM Notification regarding unquoted securities - CHM
15/12/23		27.35KB	Share
CHM Application for quotation of securities - CHM
15/12/23		33.85KB	Share
CHM Change of Director's Interest Notice PHa
14/12/23		185.13KB	Share
CHM Application for quotation of securities - CHM
07/12/23		24.93KB	Share
CHM Completion of Entitlement Offer
07/12/23	PRICE SENSITIVE	167.31KB	Share
CHM Positive in vitro data for CHM 1301 CAR NK cells-supplement
28/11/23		223.63KB	Share
CHM Program update webinar with executive team - Tuesday 28 Nov
24/11/23		208.4KB	Share
CHM Positive in vitro data for CHM 1301 CAR NK cells
23/11/23	PRICE SENSITIVE	217.9KB	Share
CHM Amended Constitution
22/11/23		573.94KB	Share
CHM Phase 1B ADVENT-AML trial to be presented at ASH meeting
20/11/23		219.57KB	Share
CHM Update - Proposed issue of securities - CHM
15/11/23		28.27KB	Share
CHM Entitlement Offer closing date extended to 30 November 2023
15/11/23		193.75KB	Share
CHM Results of Annual General Meeting
14/11/23		228.67KB	Share
CHM Presentation to Annual General Meeting
14/11/23		1.72MB	Share
CHM Notice under section 708A
03/11/23		202KB	Share
CHM Application for quotation of securities - CHM
03/11/23		25.02KB	Share
CHM 1st patient dosed in Phase 1b recurrent glioblastoma trial
02/11/23	PRICE SENSITIVE	197.43KB	Share
CHM Entitlement Offer Documents
02/11/23		4.22MB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/10/23	PRICE SENSITIVE	887.35KB	Share
CHM FDA clearance of IND for CHM 2101
31/10/23	PRICE SENSITIVE	197.28KB	Share
CHM Entitlement Offer update to timetable
25/10/23		208.91KB	Share
CHM Entitlement Offer cleansing notice under section 708AA
25/10/23		233.51KB	Share
CHM Proposed issue of securities - CHM
25/10/23		24.47KB	Share
CHM Investor Presentation - Entitlement Offer
25/10/23		2.96MB	Share
CHM Proposed issue of securities - CHM
25/10/23		28.61KB	Share
CHM Entitlement Offer to raise approximately $10 million
25/10/23	PRICE SENSITIVE	254.68KB	Share
CHM New data for Phase 1A CLTX CAR T brain cancer clinical trial
23/10/23	PRICE SENSITIVE	424.1KB	Share
CHM Trading Halt
20/10/23	PRICE SENSITIVE	568.27KB	Share
CHM Notice of Annual General Meeting/Proxy Form
16/10/23		660.58KB	Share
CHM Notice under section 708A
04/10/23		222.5KB	Share
CHM Application for quotation of securities - CHM
04/10/23		24.99KB	Share
CHM ESG Report
28/09/23		369.58KB	Share
CHM Appendix 4G
28/09/23		267.62KB	Share
CHM Corporate Governance Statement
28/09/23		164.18KB	Share
CHM Annual Report to shareholders
28/09/23		2.09MB	Share
CHM Notification regarding unquoted securities - CHM
19/09/23		23.66KB	Share
CHM Results of Extraordinary General Meeting
13/09/23		213.71KB	Share
CHM EGM Presentation
13/09/23		1.57MB	Share
CHM Agreement with MD Anderson for Phase 1B CHM 0201 AML study
13/09/23	PRICE SENSITIVE	277.45KB	Share
CHM Appendix 4E and Preliminary Final Report
31/08/23	PRICE SENSITIVE	1.06MB	Share
CHM Final Director's Interest Notice CE
31/08/23		231.55KB	Share
CHM Initial Director's Interest Notice ES
31/08/23		201.19KB	Share
CHM Non-Executive Director Board Changes
30/08/23		172.91KB	Share
CHM Dosing completion in Phase 1A brain cancer clinical trial
29/08/23	PRICE SENSITIVE	197.16KB	Share
CHM Late lodgement of Appendix 3Y
28/08/23		360.22KB	Share
CHM Chimeric to receive A$4.4 million introduction fee
16/08/23	PRICE SENSITIVE	170.91KB	Share
CHM Positive data - CHM 0301 next-gen armoured NK cell platform
15/08/23	PRICE SENSITIVE	270.01KB	Share
CHM Notice of Extraordinary General Meeting/Proxy Form
15/08/23		832.88KB	Share
CHM Final Director's Interest Notice
03/08/23		218.87KB	Share
CHM Resignation of Director
03/08/23		169.92KB	Share
CHM Quarterly Activities/Appendix 4C Cash Flow Report
31/07/23	PRICE SENSITIVE	1.24MB	Share
CHM Patent allowance for Chlorotoxin in Japan
27/07/23		170.84KB	Share
CHM Change in substantial holding PH
17/07/23		269.99KB	Share
CHM Final Director's Interest Notice LC
17/07/23		214.02KB	Share
CHM Initial Director's Interest Notice PH
17/07/23		175.02KB	Share
CHM Change of Director's Interest Notice x 6
17/07/23		333.96KB	Share
CHM Notice under section 708A
14/07/23		221.12KB	Share
CHM Notification regarding unquoted securities - CHM
14/07/23		25.97KB	Share
CHM Application for quotation of securities - CHM
14/07/23		24.69KB	Share

REFRESH

1 2 3 4

(20min delay)
Last 2.9¢		Change 0.000(0.00%)		Mkt cap ! $24.70M

Open	High	Low	Value	Volume
2.9¢	2.9¢	2.8¢	$25.82K	913.8K

Buyers (Bids)

No.	Vol.	Price($)
6	5503899	2.7¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	301388	4

View Market Depth

No.	Vol.	Price($)
6	5503899	0.027
5	798000	0.026
4	560000	0.025
10	1506666	0.024
8	2749207	0.023

Price($)	Vol.	No.
0.030	301388	4
0.031	451071	4
0.032	1550000	3
0.033	1223252	5
0.034	86001	1

Last trade - 16.10pm 03/05/2024 (20 minute delay)


Last 2.9¢		Change 0.000 ( 3.57 %)
Open	High	Low	Volume
2.8¢	2.9¢	2.7¢	743366
Last updated 15.44pm 03/05/2024 ?

CHM (ASX) Chart

CHIMERIC THERAPEUTICS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories